Prospective evaluation of non-invasive biomarkers of kidney function and musculoskeletal status with checkpoint inhibitor therapy
- Conditions
- to prospectively evaluate kidney function and musculoskeletal status in patients receiving a checkpoint inhibitor therapy
- Registration Number
- DRKS00030999
- Lead Sponsor
- niversitätsmedizin Göttingen
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 200
Inclusion Criteria
Malignant disease with indication for checkpoint inhibitor therapy according to current guidelines
Exclusion Criteria
Not capable of consent patients
Participation in clinical study with blinded use of immune therapy
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Kidney failure
- Secondary Outcome Measures
Name Time Method Musculoskeletal complaints